A simple, precise, accurate, sensitive and repeatable RP-UPLC method was developed for quantitative determination of atropine sulphate in pharmaceutical dosage form. The method was developed by using a C 18 column Hiber HR Purospher Star (100 mm×2.1 mm id, 2 µm particle size) as stationary phase with phosphate buffer:acetonitrile (87:13, v/v) as a mobile phase; pH was adjusted to 3.5 by orthophosphoric acid at a flow rate of 0.5 mL/min and the column temperature was maintained at 30 °C. Quantification of the eluted compound was achieved with a PDA detector at 210 nm. Atropine sulphate followed linearity in concentration range of 2.5-17.5 µg/mL with r 2 = 0.9998 (n = 6). Limit of detection (LOD) and limit of quantification (LOQ) values were 0.0033 and 0.0102 µg/mL for atropine sulphate. The validation study was carried out as per International Conference on Harmonization (ICH) guidelines. This method was successfully applied for the estimation of atropine sulphate in pharmaceutical formulation.
Tropane alkaloid (atropine) is extracted from deadly nightshade (Atropa belladonna), jimsonweed (Datura stramonium), mandrake (Mandragora officinarum) and other plants of the family Solanaceaeare widely used as parasympatolytic, anticholinergic and antiemetic drugs [1] . Atropine sulphate is (RS)-(1R,3r,5S)-3-tropoyloxytropanium sulphate monohydrate ( Figure 1 ). Atropine sulphate injection is official in Indian pharmacopeia, British Pharmacopeia and United States Pharmacopeia. Some methods for the determination of tropane alkaloids appearing in the literature are based on TLC [2] [3] , gas chromatography [4] , LC--MS [5, 6] , high performance liquid chromatography [7--12] , capillary zone electrophoresis [13, 14] , chiral separation [15] , with fluorescence detection [16] , with conductometric detection [17] , cation exchange [18] , ion-pair high performance chromatography [19] . To the best of our knowledge, there is no RP-UPLC method reported in literature for determination of atropine suphate. Therefore, the aim of the present work is to develop a simple, rapid, accurate and precise RP-UPLC method for determination of atropine sulphate in pharmaceutical formulation.
EXPERIMENTAL Apparatus
The chromatography was performed on a Water (Acquity) RP-UPLC instrument equipped with a PDA detector and Em-power 2 software. The column "Hiber HR Purospher Star C 18 " (100 mm×2.1 mm id, 2 µm particle size, Merck, Germany) was used. An analytical balance (Mettler Toledo, Germany) and ultrasonic cleaner (Frontline FS 4, India) were used in the preparation process.
Reagents and materials
The active pharmaceutical ingredient standard and sample were supplied by Nirlife, Healthcare division of Nirma, Ahmedabad, India. The commercial product was procured from the local market. The HPLC grade Acetonitrile and KH 2 PO 4 were purchased from Finar Reagent (Ahemedabad, India). The filter paper was Whatmann filter paper No. 41 (Whatmann International Ltd., England).
Preparation of mobile phase
To prepare the buffer solution, 6.8 gm potassium dihydrogen orthophosphate was weighed and dissolved in 1000 mL HPLC grade water. The buffer solution and HPLC grade actonitrile were mixed in a 1000 mL volumetric flask to make a mobile phase ratio buffer:acetonitrile (87:13, v/v), and the pH was adjusted to 3.5 by using orthophosphoric acid. The mobile phase was filtered and degassed in an ultrasonic bath.
Chromatographic condition
The flow rate of mobile phase was adjusted to 0.5 mL/min and the injection volume was 2 µl. The column temperature was maintained at 30 °C, while the detection wavelength was 210 nm (Figure 2 ). Preparation of standard stock Solution of atropine sulphate (500 µg/mL) Atropine sulphate standard solution containing 500 µg/mL was prepared in a 100 mL volumetric flask by dissolving 50 mg of atropine sulphate and then diluted to volume with mobile phase as a diluent.
Preparation of standard atropine sulphate injection solution (500 µg/mL) An atropine sulphate injection standard solution at concentration of 500 µg/mL was prepared in a 1000 mL volumetric flask by dissolving 1 mL of atropine sulphate injection from marketed formulation (Brand Name: atronir, label: atropine sulphate -500 mg/mL) and diluted to volume with mobile phase.
Preparation of calibration curve
A calibration curve was plotted over concentration range of 2.5-17.5 µg/mL. Aliquots (0.5, 1, 1.5, 2, 2.5, 3, and 3.5 mL) of standard stock solution were transferred in a series of 100 mL volumetric flasks and diluted with mobile phase. Each solution was injected under the operating chromatographic condition as described above and areas were recorded. A regression equation was obtained for the calibration curve by plotting the peak area versus the concentration.
Analysis of atropine sulphate Injection (500 mg/mL) Atropine sulphate injection sample solution of concentration 10 µg/mL was prepared in a 100 mL volumetric flask by diluting 2 mL of standard atropine sulphate injection solution with mobile phase. The solution was sonicated for 5 min and filtered through Whatmann filter paper No. 41. Sample solution (2 μL) was injected six times under the operating chromatographic condition as described above and areas were recorded.
RESULTS AND DISCUSSION

Optimization of chromatographic conditions
The main objective of the chromatographic method was to quantify atropine sulphate. Atropine sulphate was eluted using different stationary phases such as C 18 , C 8 , phenyl, amino and cyano as well as different mobile phases containing buffers like phosphate, sulphate, and acetate with different pH (2-5) and using organic modifiers like acetonitrile, methanol and ethanol in the mobile phase. The peak shape of the atropine sulphate was found to be symmetrical at 210 nm wavelength. In optimized chromatographic conditions, atropine sulphate was separated with typical retention time of 2.76 min.
Validation of method
The method was validated with respect to linearity, limit of detection (LOD), limit of quantitation (LOQ), accuracy, precision, ruggedness in compliance with ICH guidelines (Q2B) [20] .
System suitability parameters
The system suitability test of the proposed chromatographic method was performed before each validation run. Six replicate injections of standard solution containing 10 µg/mL atropine sulphate were injected to confirm column efficiency (theoretical plate) and tailing factor. System suitability parameters are summarized in Table 1 . Linearity A seven point calibration curve was obtained in the concentration range of 2.5-17.5 µg/mL for atropine sulphate. The response of the drug was found to be linear in the investigated range and the regression equation was found to be y = 10027x + 269 (n = 6) ( Figure 3) , with the correlation coefficient 0.9998 (n = 6), as listed in Table 2 . 
Accuracy
The accuracy of the method was determined by spiking of atropine sulphate to prequantified sample solutions of atropine sulphate (5 µg/mL) in triplicate at three concentration levels of 80, 100 and 120% of the specified limit. The percentage recoveries of atropine sulphate were calculated with RSD range of 0.07--0.11% and the results are shown in Table 3 . 
Precision
The precision of the method was evaluated in terms of inter-day and intra-day by carrying out independent assays of three concentrations chosen from the high, medium and low range of the standard curves (5, 10 and 15 µg/mL) and the RSD of assay (inter-day and intra-day) was calculated. The results are shown in Table 4 . The developed method was found to be precise as the RSD values for intra-day ranged from 0.06-0.44% and inter-day ranged from 0.13-0.61%. Limit of detection and limit of quantification
The limit of detection (LOD) and limit of quantitation (LOQ) of the method were evaluated by standard deviation of response and slope method. LOQ and LOD were calculated by the equations LOD = = 3.3N/B and LOQ = 10N/B, where N is the standard deviation of the peak areas of the drugs (n = 6), taken as a measure of noise, and B is the slope of the corresponding calibration curve. The limit of detection (LOD) and limit of quantitation (LOQ) were found to be 0.0033 and 0.0102 μg/mL, respectively.
Ruggedness
The ruggedness of the method was ascertained by repeatedly injecting (n = 6) standard solutions of atropine sulphate (10 μg/mL) without changing the chromatographic parameters with two analysts, on two different days and by using two equipment in same laboratory and calculated RSD. The result of ruggedness study is shown in Table 5 . The developed method was rugged as the RSD was less than 2 for all condition.
Validation parameters for the assay method are summarized in Table 5 . Analysis of atropine sulphate injection
The validity of the proposed assay method for pharmaceutical formulation was studied by assaying atropine sulphate injection (label claim 500 mg/mL atropine sulphate). The percentage purity was found to be 100.61% and RSD value was 0.55% by RP-UPLC ( Figure 4) .
CONCLUSION
A new, reversed-phase UPLC method has been developed for estimation of atropine sulphate in pharmaceutical dosage forms. The method was validated by employment of ICH guidelines. The validation data is indicative of good precision and accuracy, and proves the reliability of the method. The developed method has been used to monitor the atropine sulphate content in production batches.
